Add Presentation to Slide Tray Presentation:
Off-Label Use of Atypical Antipsychotics: An Update
Summary of Studies Included in the Comparative Effectiveness Review (2 of 2)
Off-label indications of atypical antipsychotics that have been studied and reported in the clinical literature are:
- Major depressive disorder (MDD)
- Obsessive-compulsive disorder (OCD)
- Borderline personality disorder (BPD)
- Post-traumatic stress disorder (PTSD)
- Substance abuse
- Eating disorders
Keywords: antipsychotics | atypical antipsychotics | off-label | second generation | dementia | major depressive disorder | obsessive-compulsive disorder | borderline personality disorder | post-traumatic stress disorder | substance abuse | eating disorders | anxiety | insomnia | MDD | OCD | BPD | PTSD
- Maglione M, Ruelaz Maher A, Hu J, et al. Off-Label Use of Atypical Antipsychotics: An Update. Comparative Effectiveness Review No. 43 (Prepared by the Southern California RAND Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; September 2011. AHRQ Publication No. 11(12)-EHC087-EF. Available at www.effectivehealthcare.ahrq.gov/offlabelantipsych.cfm.
Your slide tray is being processed.